Position in ALKS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$17,564,899
+$17,235,486 QoQ
Shares Held
335,208
+3498.2% QoQ
Ownership
0.200%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#69
of 421 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $86,377,339 across 19 Drug Manufacturers - Specialty & Generic names. ALKS ranks #2 (20.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
175,946 | $29,653,938 | |
| 2 | ALKS |
Alkermes plc.
This page
|
335,208 | $17,564,899 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
26,450 | $14,331,403 | |
| 4 | ZTS |
Zoetis Inc.
|
126,706 | $9,105,093 | |
| 5 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
305,441 | $5,485,720 | |
| 6 | BIOA |
BioAge Labs, Inc.
|
141,698 | $3,473,017 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
95,081 | $2,339,943 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
40,850 | $1,383,998 |
All Filings in ALKS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,564,899 | 335,208 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $329,413 | 9,316 | Shares | Sole | 2026-08-18 | |
| 2025-12-31 | $638,727 | 22,828 | Shares | Sole | 2026-08-18 | |
| 2025-09-30 | $1,111,230 | 37,041 | Shares | Sole | 2026-08-18 | |
| 2025-06-30 | $2,897,849 | 101,288 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $15,199,106 | 460,300 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,809,464 | 62,916 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,761,018 | 62,916 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,818,489 | 75,456 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,624,057 | 96,936 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $10,927,895 | 393,940 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $11,281,615 | 402,771 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $12,904,677 | 412,290 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $11,426,957 | 405,355 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $10,591,926 | 405,355 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $7,712,692 | 345,396 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,468,701 | 284,280 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $815,610 | 31,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $699,428 | 30,070 | Shares | Sole | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||